COMMUNIQUÉ RÉGLEMENTÉ publié le 18/03/2026 à 07:00, il y a 5 mois 21 jours Mersen : Performance résiliente en 2025, retour attendu de la croissance en 2026 Mersen affiche une performance résiliente en 2025 avec un chiffre d'affaires de 1 186 M€, une marge d'EBITDA maintenue à 16% et un retour anticipé au free cash-flow positif. Objectifs 2026 : croissance organique et marge EBITDA autour de 16% Chiffre D'affaires Croissance EBITDA Mersen Performance
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 5 mois 21 jours 2025 annual results: strong improvement in financial earnings and cash-flows Exail Technologies achieved significant financial growth in 2025 with record order intake of €844 million (+87%), revenue growth of +28%, and strengthened balance sheet post fundraising of €300 million. Operational milestones include delivering mine countermeasures to navies and increasing production capacity for navigation systems Financial Growth Record Order Intake Exail Technologies Operational Milestones Strengthened Balance Sheet
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 5 mois 21 jours Résultats annuels 2025 : forte amélioration des résultats et des flux de trésorerie
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 5 mois 21 jours Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms Sanofi Breakthrough Therapy Venglustat Gaucher Disease Neurological Symptoms
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 5 mois 21 jours Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3 Sanofi's venglustat receives innovative therapy designation in the US for Gaucher disease type 3. Positive results from the LEAP2MONO study reinforce its potential as a treatment option FDA Sanofi Innovative Therapy Venglustat Gaucher Disease
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 5 mois 21 jours Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 5 mois 21 jours SMG reports strong 2025 results with significant margin uplift SMG Swiss Marketplace Group reports strong 2025 financial results with revenue of CHF 332.0 million and Adjusted EBITDA up to CHF 180.2 million, lifting margin to 54.3%. Continues innovating with AI for user experience and efficiency Adjusted EBITDA AI Innovation Revenue Growth 2025 Financial Results SMG Swiss Marketplace Group
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 5 mois 21 jours TAG Immobilien AG exceeds guidance for the 2025 financial year TAG Immobilien AG exceeds guidance for the 2025 financial year, reporting strong financial performance and growth in Germany and Poland. Acquisitions and decarbonisation strategy milestones achieved Acquisitions Germany TAG Immobilien AG Poland 2025 Financial Year
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:30, il y a 5 mois 21 jours The 2025 annual results reflect developments in the companies and investments under the umbrella of TX Group AG TX Group AG's 2025 annual results show positive developments in marketplace activities and media companies' transformation. Revenue slightly down, operational income stable Media Companies Operating Income 2025 Annual Results TX Group AG Marketplace Activities
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:30, il y a 5 mois 21 jours Orell Füssli AG: Orell Füssli reports successful financial year 2025 Orell Füssli AG reports successful financial year 2025 with revenue up by 8% and net profit rising by 31%. Dividend proposal of CHF 5.80 per share. Strategic targets for 2028 raised Revenue Growth Dividend Proposal Strategic Targets Financial Year 2025 Orell Füssli AG
Publié le 08/09/2026 à 11:00, il y a 56 minutes MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Publié le 08/09/2026 à 11:00, il y a 56 minutes INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Publié le 08/09/2026 à 10:21, il y a 1 heure 35 minutes Disclosure of Share Capital and Voting Rights as of August 31, 2026
Publié le 08/09/2026 à 10:21, il y a 1 heure 35 minutes Déclaration du nombre d’actions et droits de vote au 31 août 2026
Publié le 08/09/2026 à 09:05, il y a 2 heures 51 minutes Battery X Metals to Appoint Accomplished Technology and Consumer Brands Executive Nicholas Reichenbach to Board of Directors
Publié le 08/09/2026 à 09:05, il y a 2 heures 51 minutes BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study
Publié le 08/09/2026 à 09:01, il y a 2 heures 55 minutes Apex Expands Trinity Zone with Step-out Hole Returning 197.5 m Interval of 2.12% REO at the Rift Rare Earth Project in SE Nebraska
Publié le 08/09/2026 à 01:45, il y a 10 heures 11 minutes Tunkillia Environmental Scoping Report Approved
Publié le 05/09/2026 à 04:05, il y a 3 jours 7 heures Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Publié le 08/09/2026 à 11:45, il y a 11 minutes Nexum Group Expands Capacity to Deliver Residential Real Estate Projects — Rainer Kunze Appointed as Technical Project Lead
Publié le 08/09/2026 à 11:07, il y a 49 minutes SBF expand industrial and commercial lighting business through partnership with CONLED
Publié le 08/09/2026 à 11:01, il y a 54 minutes CHAPTERS Group AG Raises 2026 Outlook for Organic Growth and Reports Preliminary Results for the First Half of 2026
Publié le 08/09/2026 à 10:58, il y a 58 minutes EQS-Adhoc: CHAPTERS Group AG: CHAPTERS Group AG Raises 2026 Outlook for Organic Growth